Business
Taysha Gene Therapies Announces Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy
DALLAS, May 10, 2022 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on
About this update from Taysha Gene Therapies, Inc.
[{"type":"text","content":"DALLAS, May 10, 2022 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced oral and poster presentations and a company-sponsored symposium at the upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) taking place in Washington, D.C. from May 16-19, 2022. Oral Presentations 3: Vagus Nerve Delivery of AAV9 to Treat Autonomic Nervous System Dysfunction in Giant Axonal Neuropathy Presenter – Rachel Bailey, UT SouthwesternDate/Time – Monday, May 16th at 10:45 AM Eastern TimeLocation – Room 204 470: Vectorized Delivery of Tau Reduction Therapy as a Treatment Approach for TauopathiesPresenter – Rachel Bailey, UT SouthwesternDate/Time – Tuesday, May 17th at 4:15 PM Eastern TimeLocation – Rm 204 Poster Presentations 157: Preclinical Gene Therapy with AAV9/SLC6A1 in a Mouse Model of SLC6A1 Related DisorderPresenter – Weirui Guo, UT SouthwesternDate/Time – Monday, May 16th at 5:30 PM Eastern TimeLocation – Poster Board M-38, Hall D 179: shRNA-Mediated Gene Therapy for the Treatment of Prader-Willi Syndrome Presenter – Violeta Zaric, UT SouthwesternDate/Time – Monday, May 16th at 5:30 PM Eastern TimeLocation – Poster Board M-60, Hall D 640: Gene Therapy Treatment in Young SLC13A5 Deficient MicePresenter – Rachel Bailey, UT SouthwesternDate/Time – Tuesday, May 17th at 5:30 PM Eastern TimeLocation – Poster Board Tu-145, Hall D 557: shRNA-Mediated Gene Therapy for the Treatment of Angelman Syndrome Presenter – Hye Ri Kang, UT SouthwesternDate/Time – Tuesday, May 17th at 5:30 PM Eastern TimeLocation – Poster Board Tu-62, Hall D 642: Safety and Biodistribution Assessment in Non-Human Primates (NHPs) of a miniMECP2 AAV9 Vector for Gene-Replacement Therapy of Rett Syndrome Presenter – Dr. Suyash Prasad, Taysha Gene TherapiesDate/Time – Tuesday, May 17th at 5:30 PM Eastern TimeLocation – Poster board Tu-147, Hall D 1037: Safety Assessment of High-Dose miniMECP2 AAV9 Gene-Replacement Therapy (TSHA-102) for Rett Syndrome in RatsPresenter – Mary Newman, Taysha Gene TherapiesDate/Time – Wednesday, May 18th at 5:30 PM Eastern TimeLocation –Poster board W-163, Ha...